Market by Component, Deployment Mode, and Regional Outlook | Forecast 2023-2030
Pharmaceutical supply chain
management (SCM) software is a critical tool for optimizing the entire journey
of pharmaceutical products by seamlessly coordinating their path from
manufacturing to consumption. This intricate network includes raw materials,
active ingredients, finished products, and medical devices that pass through
various stages, including manufacturing, wholesale, pharmacy distribution, and
healthcare delivery. The main objective of this software is to promote
transparency between all stakeholders to ensure the smooth and effective
distribution of products.
Pharmaceutical supply chain
solutions go beyond improving visibility and offer the benefit of automating
manual tasks. This saves time and effort for manufacturers and all other supply
chain participants. By using structured workflows and business intelligence,
these solutions can significantly reduce costs and improve the timely delivery
of critical medications to patients.
According to Triton Market Research’s analysis, the Global Pharmaceutical Supply Chain Management Market is likely to reach $4203.32 million by 2030, with a CAGR of 8.70% from $2187.73 million in 2022 during the forecast period 2023-2030.
Click here to check out our blog on the Global Pharmaceutical Supply Chain Management Market
MARKET PERFORMANCE: DRIVERS,
CHALLENGES, AND OPPORTUNITIES
Increasing demand for pharmaceutical products is
expected to fuel the studied market’s growth. This increase is due to population growth,
aging, and the rising incidence of chronic diseases. As a result,
pharmaceutical companies are under significant pressure to skillfully monitor
supply chains and ensure timely and reliable delivery of drugs and healthcare
products. In addition, the increasing integration of cloud computing solutions
in the healthcare sector and the adoption of GS1 standards will further fuel
the development of the pharmaceutical supply chain management market.
However, the substantial expenses associated
with supply chain management software and potential technical glitches in SCM
systems are anticipated to restrict the overall
market's development. Cloud-based SCM software might pose cost challenges
for smaller pharmaceutical firms, impeding their capacity to enhance supply
chain processes. Additionally, the ongoing need for software maintenance and
updates could exacerbate financial burdens, negatively impacting the market's
advancement.
Despite these restrictions, advancements in the
clinically integrated supply chain are likely to create lucrative opportunities
for the pharmaceutical supply chain management market. Technology is critical in supply chain
planning, synchronization, and collaboration. Integrating advanced technologies
into the pharmaceutical supply chain increases efficiency and reduces costs.
Moreover, this synergy ultimately improves the quality and the level of service
offered.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe:
United Kingdom, France, Nordic Countries, Germany, Spain, Italy, and Rest of
Europe
• Asia-Pacific:
China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries,
and Rest of Asia-Pacific
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and
Rest of Middle East & Africa
SEGMENTATION ANALYSIS -
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
• Market
by Component:
o Solution
• Transportation
Management System
• Planning
and Analytics
• Warehouse
and Inventory Management System
• Procurement
and Sourcing
• Manufacturing
and Execution System
o Service
• Professional
Services
• Managed
Services
The service category leads the component segment
with the largest share. These
service providers go beyond providing information, real-time insights, and
actionable recommendations that shorten the time to resolve incidents and turn
days into hours. In addition, these services play a critical role in reducing
the time, cost, and risk associated with validating, qualifying, and monitoring
new suppliers, enabling rapid responses to supplier-related challenges.
• Market by Deployment Mode:
o On-premise
o Cloud-based
Cloud-based is expected to witness the fastest growth in the deployment mode segment. These software solutions have seen a resurgence, especially in healthcare manufacturing. Moreover, the platforms revolutionize supply chain management processes and benefit small businesses and complex operations. Manufacturers who initially anticipated modest or gradual demand have enjoyed a significant increase in orders and purchasing activity from new and existing customers.
COMPETITIVE LANDSCAPE:
The pharmaceutical supply chain management market by company profiles
helps drive into data about the key players in this industry. The strategic
initiatives for each of the companies considered have been covered in detail.
Collaboration (July 2023): SY
Holdings Group and IFP CQ Pharmaceutical
SY Holdings Group Limited strategically allocated SGD 500 million
($375.45 million) in collaboration with CQ Pharmaceutical. This initiative is
geared towards augmenting its supply chain and strengthening business connectivity
linking China and Singapore.
Product Launch (May 2020):
IBM Corporation and Rapid Supplier Connect
IBM Corporation unveiled ‘Rapid Supplier Connect,’ a blockchain network
designed to strengthen the medical supply chain. This innovative solution was
designed to optimize the efficiency and reliability of the medical supply
chain.
KEY BENEFITS OF THE REPORT:
●
Triton Market Research has a collective experience of 25-30 years
in the industry, with its analysts and experts encompassing the most infallible
research methodology for its market intelligence and industry analysis.
●
Our research methodology helps achieve a broader consensus of each
segment's market size, shape, and industry trends.
●
The strategy adopted in designing the research methodology
includes amalgamating the information assembled from primary and secondary
sources and using analytical tools to construct the forecast and predictive
models.
●
The scope of the market report comprises the current scenario of
the global pharmaceutical supply chain management market, along with a detailed
overview of the industry outlook, market dynamics, segmentation analysis,
regional outlook, and competitive landscape for 2023-2030.
FAQs:
Q1) How does supply chain management (SCM)
contribute to sustainability and social responsibility?
Supply chain management (SCM) contributes to sustainability by
optimizing transportation routes for lower carbon emissions, advocating
environmentally friendly packaging, ensuring ethical sourcing and supplier
practices, and reducing waste through improved inventory management.
Q2) How is globalization
impacting the pharmaceutical
supply chain management market?
Globalization has extended supply chains across countries and continents
and increased their complexity. This evolution necessitates using advanced
solutions to monitor global sourcing, transportation, and compliance
effectively.
Q3)
Which region holds the largest share of the pharmaceutical supply chain management market?
Asia-Pacific holds the largest share of the pharmaceutical supply chain management market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
MATURITY ANALYSIS
2.5. REGULATORY
FRAMEWORK
2.6. KEY
BUYING IMPACT ANALYSIS
2.6.1. COMPETITIVE
PRICING
2.6.2. INTEGRATION
CAPABILITIES
2.6.3. INVENTORY
MANAGEMENT
2.6.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.6.5. SECURITY
AND DATA PRIVACY
2.7. KEY
MARKET STRATEGIES
2.7.1. COLLABORATIONS
2.7.2. PRODUCT
LAUNCHES
2.8. MARKET
DRIVERS
2.8.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.8.2. IMPLEMENTATION
OF GS1 STANDARD
2.8.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.8.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.8.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.9. MARKET
CHALLENGES
2.9.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.9.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.9.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.9.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.10. MARKET
OPPORTUNITIES
2.10.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAINS
2.10.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY COMPONENT
5.1.1.1. MARKET
BY SOLUTION
5.1.1.2. MARKET
BY SERVICE
5.1.2. MARKET
BY DEPLOYMENT MODE
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. UNITED
STATES
5.1.3.1.1. UNITED
STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.3.2. CANADA
5.1.3.2.1. CANADA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2. EUROPE
5.2.1. MARKET
BY COMPONENT
5.2.1.1. MARKET
BY SOLUTION
5.2.1.2. MARKET
BY SERVICE
5.2.2. MARKET
BY DEPLOYMENT MODE
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. UNITED
KINGDOM
5.2.3.1.1. UNITED
KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2.3.2. GERMANY
5.2.3.2.1. GERMANY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2.3.3. FRANCE
5.2.3.3.1. FRANCE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2.3.4. ITALY
5.2.3.4.1. ITALY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2.3.5. SPAIN
5.2.3.5.1. SPAIN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.2.3.6. NORDIC
COUNTRIES
5.2.3.6.1. NORDIC
COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.2.3.7. REST
OF EUROPE
5.2.3.7.1. REST
OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.3. ASIA-PACIFIC
5.3.1. MARKET
BY COMPONENT
5.3.1.1. MARKET
BY SOLUTION
5.3.1.2. MARKET
BY SERVICE
5.3.2. MARKET
BY DEPLOYMENT MODE
5.3.3. COUNTRY
ANALYSIS
5.3.3.1. CHINA
5.3.3.1.1. CHINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.3.3.2. JAPAN
5.3.3.2.1. JAPAN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.3.3.3. INDIA
5.3.3.3.1. INDIA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.3.3.4. SOUTH
KOREA
5.3.3.4.1. SOUTH
KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.3.3.5. ASEAN
COUNTRIES
5.3.3.5.1. ASEAN
COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.3.3.6. AUSTRALIA
& NEW ZEALAND
5.3.3.6.1. AUSTRALIA
& NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.3.3.7. REST
OF ASIA-PACIFIC
5.3.3.7.1. REST
OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.4. LATIN
AMERICA
5.4.1. MARKET
BY COMPONENT
5.4.1.1. MARKET
BY SOLUTION
5.4.1.2. MARKET
BY SERVICE
5.4.2. MARKET
BY DEPLOYMENT MODE
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.1.1. BRAZIL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.4.3.2. MEXICO
5.4.3.2.1. MEXICO
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.4.3.3. ARGENTINA
5.4.3.3.1. ARGENTINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.4.3.4. REST
OF LATIN AMERICA
5.4.3.4.1. REST
OF LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY COMPONENT
5.5.1.1. MARKET
BY SOLUTION
5.5.1.2. MARKET
BY SERVICE
5.5.2. MARKET
BY DEPLOYMENT MODE
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. UNITED
ARAB EMIRATES
5.5.3.1.1. UNITED
ARAB EMIRATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.5.3.2. TURKEY
5.5.3.2.1. TURKEY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.5.3.3. SAUDI
ARABIA
5.5.3.3.1. SAUDI
ARABIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.5.3.4. SOUTH
AFRICA
5.5.3.4.1. SOUTH AFRICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
5.5.3.5.1. REST
OF MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
FORECAST & PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: GLOBAL PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $ MILLION)
TABLE 7: GLOBAL PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $ MILLION)
TABLE 8: GLOBAL PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $ MILLION)
TABLE 9: GLOBAL PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 11: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 12: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 13: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 14: NORTH AMERICA PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $ MILLION)
TABLE 15: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 16: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 17: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 18: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 19: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 20: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 21: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 22: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 23: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 24: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 25: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 26: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 27: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 28: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 29: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 30: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 31: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK,
2023-2030 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030
(IN $ MILLION)
TABLE 33: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030
(IN $ MILLION)
TABLE 34: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN
$ MILLION)
TABLE 35: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE,
2023-2030 (IN $ MILLION)
FIGURE 1: MARKET MATURITY
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 & 2030
(IN %)
FIGURE 4: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 & 2030 (IN
%)
FIGURE 5: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 6: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND ANALYTICS,
2023-2030 (IN $ MILLION)
FIGURE 7: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND INVENTORY
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 8: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING,
2023-2030 (IN $ MILLION)
FIGURE 9: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 & 2030 (IN
%)
FIGURE 11: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 12: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030
(IN $ MILLION)
FIGURE 13: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022 &
2030 (IN %)
FIGURE 14: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $
MILLION)
FIGURE 15: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $
MILLION)
FIGURE 16: GLOBAL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022 &
2030 (IN %)
FIGURE 17: UNITED STATES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: CANADA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: UNITED KINGDOM
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: GERMANY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: FRANCE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: ITALY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 23: SPAIN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 24: NORDIC COUNTRIES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 25: REST OF EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 26: CHINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 27: JAPAN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: INDIA PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: SOUTH KOREA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: ASEAN COUNTRIES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: AUSTRALIA & NEW
ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 32: REST OF ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 33: BRAZIL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 34: MEXICO
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 35: ARGENTINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 36: REST OF LATIN
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 37: UNITED ARAB
EMIRATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 38: TURKEY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 39: SAUDI ARABIA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 40: SOUTH AFRICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 41: REST OF MIDDLE EAST
& AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $
MILLION)